Nuway Organic Naturals India Limited
Nuway Organic Naturals India Limited (NUWAY.BO) Stock Competitors & Peer Comparison
See (NUWAY.BO) competitors and their performances in Stock Market.
Peer Comparison Table: Household & Personal Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NUWAY.BO | ₹37.00 | +0.00% | 354.6M | 14.40 | ₹2.57 | N/A |
| HINDUNILVR.BO | ₹2,089.10 | +0.68% | 4.8T | 44.46 | ₹46.24 | +2.09% |
| HINDUNILVR.NS | ₹2,089.30 | +0.72% | 4.8T | 47.86 | ₹42.94 | +2.09% |
| GODREJCP.NS | ₹1,000.75 | -0.79% | 1T | 55.17 | ₹17.85 | +1.98% |
| GODREJCP.BO | ₹1,005.00 | -0.39% | 1T | 55.29 | ₹17.81 | +1.98% |
| MARICO.BO | ₹752.00 | +1.18% | 953.7B | 55.78 | ₹13.20 | +1.43% |
| MARICO.NS | ₹750.85 | +1.13% | 953.3B | 55.54 | ₹13.25 | +1.43% |
| DABUR.NS | ₹417.75 | -0.44% | 728B | 39.54 | ₹10.38 | +1.95% |
| DABUR.BO | ₹418.45 | -0.30% | 727.9B | 39.58 | ₹10.37 | +1.95% |
| COLPAL.BO | ₹1,840.00 | -2.00% | 486.6B | 36.60 | ₹48.88 | +2.85% |
Stock Comparison
NUWAY.BO vs HINDUNILVR.BO Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, HINDUNILVR.BO has a market cap of 4.8T. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while HINDUNILVR.BO trades at ₹2,089.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas HINDUNILVR.BO's P/E ratio is 44.46. In terms of profitability, NUWAY.BO's ROE is N/A, compared to HINDUNILVR.BO's ROE of +0.29%. Regarding short-term risk, NUWAY.BO is less volatile compared to HINDUNILVR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NUWAY.BO.Check HINDUNILVR.BO's competition here
NUWAY.BO vs HINDUNILVR.NS Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, HINDUNILVR.NS has a market cap of 4.8T. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while HINDUNILVR.NS trades at ₹2,089.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas HINDUNILVR.NS's P/E ratio is 47.86. In terms of profitability, NUWAY.BO's ROE is N/A, compared to HINDUNILVR.NS's ROE of +0.29%. Regarding short-term risk, NUWAY.BO is less volatile compared to HINDUNILVR.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NUWAY.BO.Check HINDUNILVR.NS's competition here
NUWAY.BO vs GODREJCP.NS Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, GODREJCP.NS has a market cap of 1T. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while GODREJCP.NS trades at ₹1,000.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas GODREJCP.NS's P/E ratio is 55.17. In terms of profitability, NUWAY.BO's ROE is N/A, compared to GODREJCP.NS's ROE of +0.15%. Regarding short-term risk, NUWAY.BO is less volatile compared to GODREJCP.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NUWAY.BO.Check GODREJCP.NS's competition here
NUWAY.BO vs GODREJCP.BO Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, GODREJCP.BO has a market cap of 1T. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while GODREJCP.BO trades at ₹1,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas GODREJCP.BO's P/E ratio is 55.29. In terms of profitability, NUWAY.BO's ROE is N/A, compared to GODREJCP.BO's ROE of +0.15%. Regarding short-term risk, NUWAY.BO is less volatile compared to GODREJCP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NUWAY.BO.Check GODREJCP.BO's competition here
NUWAY.BO vs MARICO.BO Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, MARICO.BO has a market cap of 953.7B. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while MARICO.BO trades at ₹752.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas MARICO.BO's P/E ratio is 55.78. In terms of profitability, NUWAY.BO's ROE is N/A, compared to MARICO.BO's ROE of +0.40%. Regarding short-term risk, NUWAY.BO is less volatile compared to MARICO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NUWAY.BO.Check MARICO.BO's competition here
NUWAY.BO vs MARICO.NS Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, MARICO.NS has a market cap of 953.3B. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while MARICO.NS trades at ₹750.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas MARICO.NS's P/E ratio is 55.54. In terms of profitability, NUWAY.BO's ROE is N/A, compared to MARICO.NS's ROE of +0.40%. Regarding short-term risk, NUWAY.BO is less volatile compared to MARICO.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NUWAY.BO.Check MARICO.NS's competition here
NUWAY.BO vs DABUR.NS Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, DABUR.NS has a market cap of 728B. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while DABUR.NS trades at ₹417.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas DABUR.NS's P/E ratio is 39.54. In terms of profitability, NUWAY.BO's ROE is N/A, compared to DABUR.NS's ROE of +0.17%. Regarding short-term risk, NUWAY.BO is less volatile compared to DABUR.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NUWAY.BO.Check DABUR.NS's competition here
NUWAY.BO vs DABUR.BO Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, DABUR.BO has a market cap of 727.9B. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while DABUR.BO trades at ₹418.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas DABUR.BO's P/E ratio is 39.58. In terms of profitability, NUWAY.BO's ROE is N/A, compared to DABUR.BO's ROE of +0.17%. Regarding short-term risk, NUWAY.BO is less volatile compared to DABUR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NUWAY.BO.Check DABUR.BO's competition here
NUWAY.BO vs COLPAL.BO Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, COLPAL.BO has a market cap of 486.6B. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while COLPAL.BO trades at ₹1,840.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas COLPAL.BO's P/E ratio is 36.60. In terms of profitability, NUWAY.BO's ROE is N/A, compared to COLPAL.BO's ROE of +0.81%. Regarding short-term risk, NUWAY.BO is less volatile compared to COLPAL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NUWAY.BO.Check COLPAL.BO's competition here
NUWAY.BO vs COLPAL.NS Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, COLPAL.NS has a market cap of 486.5B. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while COLPAL.NS trades at ₹1,839.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas COLPAL.NS's P/E ratio is 36.65. In terms of profitability, NUWAY.BO's ROE is N/A, compared to COLPAL.NS's ROE of +0.81%. Regarding short-term risk, NUWAY.BO is less volatile compared to COLPAL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NUWAY.BO.Check COLPAL.NS's competition here
NUWAY.BO vs PGHH.BO Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, PGHH.BO has a market cap of 302.7B. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while PGHH.BO trades at ₹9,601.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas PGHH.BO's P/E ratio is 42.13. In terms of profitability, NUWAY.BO's ROE is N/A, compared to PGHH.BO's ROE of +1.01%. Regarding short-term risk, NUWAY.BO is less volatile compared to PGHH.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NUWAY.BO.Check PGHH.BO's competition here
NUWAY.BO vs PGHH.NS Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, PGHH.NS has a market cap of 302.6B. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while PGHH.NS trades at ₹9,660.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas PGHH.NS's P/E ratio is 42.33. In terms of profitability, NUWAY.BO's ROE is N/A, compared to PGHH.NS's ROE of +1.01%. Regarding short-term risk, NUWAY.BO is less volatile compared to PGHH.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NUWAY.BO.Check PGHH.NS's competition here
NUWAY.BO vs GILLETTE.NS Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, GILLETTE.NS has a market cap of 236.4B. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while GILLETTE.NS trades at ₹7,481.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas GILLETTE.NS's P/E ratio is 44.25. In terms of profitability, NUWAY.BO's ROE is N/A, compared to GILLETTE.NS's ROE of +0.58%. Regarding short-term risk, NUWAY.BO is less volatile compared to GILLETTE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NUWAY.BO.Check GILLETTE.NS's competition here
NUWAY.BO vs GILLETTE.BO Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, GILLETTE.BO has a market cap of 236.2B. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while GILLETTE.BO trades at ₹7,493.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas GILLETTE.BO's P/E ratio is 44.25. In terms of profitability, NUWAY.BO's ROE is N/A, compared to GILLETTE.BO's ROE of +0.58%. Regarding short-term risk, NUWAY.BO is less volatile compared to GILLETTE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NUWAY.BO.Check GILLETTE.BO's competition here
NUWAY.BO vs EMAMILTD.NS Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, EMAMILTD.NS has a market cap of 171.7B. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while EMAMILTD.NS trades at ₹398.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas EMAMILTD.NS's P/E ratio is 21.62. In terms of profitability, NUWAY.BO's ROE is N/A, compared to EMAMILTD.NS's ROE of +0.29%. Regarding short-term risk, NUWAY.BO is less volatile compared to EMAMILTD.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NUWAY.BO.Check EMAMILTD.NS's competition here
NUWAY.BO vs EMAMILTD.BO Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, EMAMILTD.BO has a market cap of 171.6B. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while EMAMILTD.BO trades at ₹398.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas EMAMILTD.BO's P/E ratio is 21.59. In terms of profitability, NUWAY.BO's ROE is N/A, compared to EMAMILTD.BO's ROE of +0.29%. Regarding short-term risk, NUWAY.BO is less volatile compared to EMAMILTD.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NUWAY.BO.Check EMAMILTD.BO's competition here
NUWAY.BO vs CUPID.BO Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, CUPID.BO has a market cap of 111.8B. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while CUPID.BO trades at ₹87.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas CUPID.BO's P/E ratio is 134.11. In terms of profitability, NUWAY.BO's ROE is N/A, compared to CUPID.BO's ROE of +0.24%. Regarding short-term risk, NUWAY.BO is less volatile compared to CUPID.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NUWAY.BO.Check CUPID.BO's competition here
NUWAY.BO vs CUPID.NS Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, CUPID.NS has a market cap of 111.7B. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while CUPID.NS trades at ₹88.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas CUPID.NS's P/E ratio is 134.03. In terms of profitability, NUWAY.BO's ROE is N/A, compared to CUPID.NS's ROE of +0.24%. Regarding short-term risk, NUWAY.BO is less volatile compared to CUPID.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NUWAY.BO.Check CUPID.NS's competition here
NUWAY.BO vs HONASA.NS Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, HONASA.NS has a market cap of 97B. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while HONASA.NS trades at ₹307.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas HONASA.NS's P/E ratio is 62.53. In terms of profitability, NUWAY.BO's ROE is N/A, compared to HONASA.NS's ROE of +0.13%. Regarding short-term risk, NUWAY.BO is less volatile compared to HONASA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NUWAY.BO.Check HONASA.NS's competition here
NUWAY.BO vs HONASA.BO Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, HONASA.BO has a market cap of 97B. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while HONASA.BO trades at ₹303.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas HONASA.BO's P/E ratio is 62.51. In terms of profitability, NUWAY.BO's ROE is N/A, compared to HONASA.BO's ROE of +0.13%. Regarding short-term risk, NUWAY.BO is less volatile compared to HONASA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NUWAY.BO.Check HONASA.BO's competition here
NUWAY.BO vs JYOTHYLAB.NS Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, JYOTHYLAB.NS has a market cap of 72.4B. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while JYOTHYLAB.NS trades at ₹206.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas JYOTHYLAB.NS's P/E ratio is 21.19. In terms of profitability, NUWAY.BO's ROE is N/A, compared to JYOTHYLAB.NS's ROE of +0.18%. Regarding short-term risk, NUWAY.BO is less volatile compared to JYOTHYLAB.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NUWAY.BO.Check JYOTHYLAB.NS's competition here
NUWAY.BO vs JYOTHYLAB.BO Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, JYOTHYLAB.BO has a market cap of 72.4B. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while JYOTHYLAB.BO trades at ₹205.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas JYOTHYLAB.BO's P/E ratio is 21.19. In terms of profitability, NUWAY.BO's ROE is N/A, compared to JYOTHYLAB.BO's ROE of +0.18%. Regarding short-term risk, NUWAY.BO is less volatile compared to JYOTHYLAB.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NUWAY.BO.Check JYOTHYLAB.BO's competition here
NUWAY.BO vs BAJAJCON.NS Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, BAJAJCON.NS has a market cap of 45.6B. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while BAJAJCON.NS trades at ₹361.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas BAJAJCON.NS's P/E ratio is 29.84. In terms of profitability, NUWAY.BO's ROE is N/A, compared to BAJAJCON.NS's ROE of +0.22%. Regarding short-term risk, NUWAY.BO is less volatile compared to BAJAJCON.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NUWAY.BO.Check BAJAJCON.NS's competition here
NUWAY.BO vs BAJAJCON.BO Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, BAJAJCON.BO has a market cap of 45.4B. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while BAJAJCON.BO trades at ₹362.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas BAJAJCON.BO's P/E ratio is 29.76. In terms of profitability, NUWAY.BO's ROE is N/A, compared to BAJAJCON.BO's ROE of +0.22%. Regarding short-term risk, NUWAY.BO is less volatile compared to BAJAJCON.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NUWAY.BO.Check BAJAJCON.BO's competition here
NUWAY.BO vs SHK.NS Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, SHK.NS has a market cap of 15.6B. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while SHK.NS trades at ₹121.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas SHK.NS's P/E ratio is 9.13. In terms of profitability, NUWAY.BO's ROE is N/A, compared to SHK.NS's ROE of +0.13%. Regarding short-term risk, NUWAY.BO is less volatile compared to SHK.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NUWAY.BO.Check SHK.NS's competition here
NUWAY.BO vs ALLTIME.NS Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, ALLTIME.NS has a market cap of 12.3B. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while ALLTIME.NS trades at ₹197.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas ALLTIME.NS's P/E ratio is 34.42. In terms of profitability, NUWAY.BO's ROE is N/A, compared to ALLTIME.NS's ROE of +0.08%. Regarding short-term risk, NUWAY.BO is less volatile compared to ALLTIME.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NUWAY.BO.Check ALLTIME.NS's competition here
NUWAY.BO vs BCLIND.NS Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, BCLIND.NS has a market cap of 7.7B. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while BCLIND.NS trades at ₹27.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas BCLIND.NS's P/E ratio is 6.56. In terms of profitability, NUWAY.BO's ROE is N/A, compared to BCLIND.NS's ROE of +0.14%. Regarding short-term risk, NUWAY.BO is less volatile compared to BCLIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NUWAY.BO.Check BCLIND.NS's competition here
NUWAY.BO vs KAYA.NS Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, KAYA.NS has a market cap of 3.6B. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while KAYA.NS trades at ₹250.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas KAYA.NS's P/E ratio is -4.20. In terms of profitability, NUWAY.BO's ROE is N/A, compared to KAYA.NS's ROE of +0.62%. Regarding short-term risk, NUWAY.BO is less volatile compared to KAYA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NUWAY.BO.Check KAYA.NS's competition here
NUWAY.BO vs KAYA.BO Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, KAYA.BO has a market cap of 3.6B. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while KAYA.BO trades at ₹238.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas KAYA.BO's P/E ratio is -4.20. In terms of profitability, NUWAY.BO's ROE is N/A, compared to KAYA.BO's ROE of +0.62%. Regarding short-term risk, NUWAY.BO is more volatile compared to KAYA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NUWAY.BO.Check KAYA.BO's competition here
NUWAY.BO vs ADORMUL.BO Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, ADORMUL.BO has a market cap of 1.3B. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while ADORMUL.BO trades at ₹135.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas ADORMUL.BO's P/E ratio is -29.80. In terms of profitability, NUWAY.BO's ROE is N/A, compared to ADORMUL.BO's ROE of -0.32%. Regarding short-term risk, NUWAY.BO is less volatile compared to ADORMUL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NUWAY.BO.Check ADORMUL.BO's competition here
NUWAY.BO vs PCCOSMA.BO Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, PCCOSMA.BO has a market cap of 781.3M. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while PCCOSMA.BO trades at ₹311.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas PCCOSMA.BO's P/E ratio is 9.75. In terms of profitability, NUWAY.BO's ROE is N/A, compared to PCCOSMA.BO's ROE of +0.16%. Regarding short-term risk, NUWAY.BO is less volatile compared to PCCOSMA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NUWAY.BO.Check PCCOSMA.BO's competition here
NUWAY.BO vs JHS.NS Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, JHS.NS has a market cap of 560.7M. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while JHS.NS trades at ₹7.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas JHS.NS's P/E ratio is -10.40. In terms of profitability, NUWAY.BO's ROE is N/A, compared to JHS.NS's ROE of -0.03%. Regarding short-term risk, NUWAY.BO is less volatile compared to JHS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NUWAY.BO.Check JHS.NS's competition here
NUWAY.BO vs JHS.BO Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, JHS.BO has a market cap of 555.9M. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while JHS.BO trades at ₹7.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas JHS.BO's P/E ratio is -6.99. In terms of profitability, NUWAY.BO's ROE is N/A, compared to JHS.BO's ROE of -0.03%. Regarding short-term risk, NUWAY.BO is less volatile compared to JHS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NUWAY.BO.Check JHS.BO's competition here
NUWAY.BO vs STDSFAC.BO Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, STDSFAC.BO has a market cap of 400.4M. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while STDSFAC.BO trades at ₹50.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas STDSFAC.BO's P/E ratio is N/A. In terms of profitability, NUWAY.BO's ROE is N/A, compared to STDSFAC.BO's ROE of N/A. Regarding short-term risk, NUWAY.BO is more volatile compared to STDSFAC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NUWAY.BO.Check STDSFAC.BO's competition here
NUWAY.BO vs NKIND.NS Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, NKIND.NS has a market cap of 366.6M. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while NKIND.NS trades at ₹61.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas NKIND.NS's P/E ratio is -5.92. In terms of profitability, NUWAY.BO's ROE is N/A, compared to NKIND.NS's ROE of +0.02%. Regarding short-term risk, NUWAY.BO is less volatile compared to NKIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NUWAY.BO.Check NKIND.NS's competition here
NUWAY.BO vs AMBICAAGAR.BO Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, AMBICAAGAR.BO has a market cap of 358.1M. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while AMBICAAGAR.BO trades at ₹22.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas AMBICAAGAR.BO's P/E ratio is 71.90. In terms of profitability, NUWAY.BO's ROE is N/A, compared to AMBICAAGAR.BO's ROE of +0.01%. Regarding short-term risk, NUWAY.BO is more volatile compared to AMBICAAGAR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NUWAY.BO.Check AMBICAAGAR.BO's competition here
NUWAY.BO vs AMBICAAGAR.NS Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, AMBICAAGAR.NS has a market cap of 353M. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while AMBICAAGAR.NS trades at ₹22.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas AMBICAAGAR.NS's P/E ratio is 27.77. In terms of profitability, NUWAY.BO's ROE is N/A, compared to AMBICAAGAR.NS's ROE of +0.01%. Regarding short-term risk, NUWAY.BO is less volatile compared to AMBICAAGAR.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NUWAY.BO.Check AMBICAAGAR.NS's competition here
NUWAY.BO vs NKIND.BO Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, NKIND.BO has a market cap of 330.7M. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while NKIND.BO trades at ₹55.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas NKIND.BO's P/E ratio is -5.34. In terms of profitability, NUWAY.BO's ROE is N/A, compared to NKIND.BO's ROE of +0.02%. Regarding short-term risk, NUWAY.BO is less volatile compared to NKIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NUWAY.BO.Check NKIND.BO's competition here
NUWAY.BO vs PAOS.BO Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, PAOS.BO has a market cap of 292.4M. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while PAOS.BO trades at ₹47.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas PAOS.BO's P/E ratio is -9.05. In terms of profitability, NUWAY.BO's ROE is N/A, compared to PAOS.BO's ROE of +0.22%. Regarding short-term risk, NUWAY.BO is more volatile compared to PAOS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NUWAY.BO.Check PAOS.BO's competition here
NUWAY.BO vs SATTVASUKU.BO Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, SATTVASUKU.BO has a market cap of 280M. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while SATTVASUKU.BO trades at ₹0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas SATTVASUKU.BO's P/E ratio is -73.00. In terms of profitability, NUWAY.BO's ROE is N/A, compared to SATTVASUKU.BO's ROE of +0.12%. Regarding short-term risk, NUWAY.BO is less volatile compared to SATTVASUKU.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NUWAY.BO.Check SATTVASUKU.BO's competition here
NUWAY.BO vs PARMCOS-B.BO Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, PARMCOS-B.BO has a market cap of 167.5M. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while PARMCOS-B.BO trades at ₹35.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas PARMCOS-B.BO's P/E ratio is 164.29. In terms of profitability, NUWAY.BO's ROE is N/A, compared to PARMCOS-B.BO's ROE of +0.00%. Regarding short-term risk, NUWAY.BO is more volatile compared to PARMCOS-B.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NUWAY.BO.Check PARMCOS-B.BO's competition here
NUWAY.BO vs HIPOLIN.BO Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, HIPOLIN.BO has a market cap of 146.5M. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while HIPOLIN.BO trades at ₹46.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas HIPOLIN.BO's P/E ratio is -4.68. In terms of profitability, NUWAY.BO's ROE is N/A, compared to HIPOLIN.BO's ROE of -0.35%. Regarding short-term risk, NUWAY.BO is less volatile compared to HIPOLIN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NUWAY.BO.Check HIPOLIN.BO's competition here
NUWAY.BO vs CORNE.BO Comparison April 2026
NUWAY.BO plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUWAY.BO stands at 354.6M. In comparison, CORNE.BO has a market cap of 46.8M. Regarding current trading prices, NUWAY.BO is priced at ₹37.00, while CORNE.BO trades at ₹9.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUWAY.BO currently has a P/E ratio of 14.40, whereas CORNE.BO's P/E ratio is -5.51. In terms of profitability, NUWAY.BO's ROE is N/A, compared to CORNE.BO's ROE of +0.09%. Regarding short-term risk, NUWAY.BO is more volatile compared to CORNE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NUWAY.BO.Check CORNE.BO's competition here